Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
A UK Business, Energy and Industrial Strategy Committee report found that leaving the EU without an agreement for the phar- maceutical industry would diminish access to markets, including £11.9 billion of exports, and to more than 446 million potential patients and consumers in the EU. British patients’ access to medicines would also be at risk, with nearly three-quarters of phar- maceutical imports coming from the EU.
[/membership]
